Nasonex mometasone furoate: Post-marketing study data

Data from a placebo-controlled trial in 299 patients showed that 200 µg once-daily Nasonex for 16 weeks met both the primary and secondary endpoints. Nasal congestion was improved in 74.3% of the pati...